Glenn A. Edwards

No ORCID on file · 4 papers in corpus
article 2014
·doi:10.1007/s11095-013-1260-8

PurposeTo explore the possibility that age-related changes in physiology may result in differences in drug bioavailability after oral administration of lipid based formulations of danazol.MethodsDanazol absorption from lipid formulations wi…

article 2007
·doi:10.1002/jps.21246

Lipid-based formulations of danazol with varying quantities of included surfactant have been examined in vitro and in vivo. Formulations comprising fatty acid ester surfactants were readily hydrolysed during in vitro digestion, although Cre…

article 2007
·doi:10.1007/s11095-006-9194-z

PurposeTo investigate the impact of a change in the proportions of lipid, surfactant and co-solvent on the solubilisation capacity of self-emulsifying formulations of danazol during in vitro dispersion and digestion studies and correlation …

article 2004
·doi:10.1023/b:pham.0000036914.22132.cc

PurposeTo investigate the impact of lipidic formulation type on in vitro dispersion and digestion properties and the relationship to oral bioavailability, using danazol as a model lipophilic poorly water-soluble drug.MethodsThree lipid-base…